Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rapidly Progressive Diffuse Lewy Body Disease

Identifieur interne : 000542 ( PascalFrancis/Corpus ); précédent : 000541; suivant : 000543

Rapidly Progressive Diffuse Lewy Body Disease

Auteurs : Carles Gaig ; Francesc Valldeoriola ; Ellen Gelpi ; Mario Ezquerra ; Sara Llufriu ; Mariateresa Buongiorno ; Maria Jesus Rey ; Maria Jose Marti ; Francesc Graus ; Eduardo Tolosa

Source :

RBID : Pascal:11-0321224

Descripteurs français

English descriptors

Abstract

Background: Lewy body syndromes (mainly Parkinson's disease and dementia with Lewy bodies) share many clinical features and usually have a slowly progressive course. Some patients may show rapid symptoms progression. Objective: To evaluate clinical and neuropathological features of patients with a rapidly progressive diffuse Lewy Body disease. Methods: Review clinical records and pathological findings of 6 cases with diffuse Lewy Body disease and rapid disease progression (less than 18 months before death). Results: Mean age at disease onset was 72.5 years, and mean disease duration was 9 months. Onset consisted of delirium in 3 patients and rapidly progressive dementia in the other three. All cases presented visual hallucinations and delusions; cognitive symptoms were fluctuating in two, parkinsonism occurred in four, and myoclonus in three. Brain MRI did not show cortical or basal ganglia hyperintensities. Periodic sharp waves were absent on EEG. 14.3.3 protein in CSF was negative. Myocardial 123I-metaiodo-benzyl-guanidine SPECT showed marked reduction in tracer uptake in the 2 patients tested. Neuropathological studies did not identify any particular feature that could differentiate rapidly progressive diffuse Lewy body disease from classical diffuse Lewy body disease. Conclusions: Diffuse Lewy body disease is a possible cause of rapidly progressive dementia and should be included in the differential diagnosis of confusional states of undetermined cause. In patients with rapidly progressive dementia, the presence of fluctuating cognition, parkinsonism, hallucinations, delusions, or severe dysautonomia, should raise the suspicion of diffuse Lewy body disease. Neuroimaging studies such as 123I-metaiodo-benzyl-guanidine myocardial scintigraphy may support the clinical diagnosis of diffuse Lewy body disease.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 26
A06       @2 7
A08 01  1  ENG  @1 Rapidly Progressive Diffuse Lewy Body Disease
A11 01  1    @1 GAIG (Carles)
A11 02  1    @1 VALLDEORIOLA (Francesc)
A11 03  1    @1 GELPI (Ellen)
A11 04  1    @1 EZQUERRA (Mario)
A11 05  1    @1 LLUFRIU (Sara)
A11 06  1    @1 BUONGIORNO (Mariateresa)
A11 07  1    @1 JESUS REY (Maria)
A11 08  1    @1 JOSE MARTI (Maria)
A11 09  1    @1 GRAUS (Francesc)
A11 10  1    @1 TOLOSA (Eduardo)
A14 01      @1 Neurology Service, Hospital Clinic of Barcelona @2 Barcelona @3 ESP @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 8 aut. @Z 9 aut. @Z 10 aut.
A14 02      @1 Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic @2 Barcelona @3 ESP @Z 1 aut. @Z 3 aut. @Z 7 aut. @Z 9 aut.
A20       @1 1316-1323
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000190480410180
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 36 ref.
A47 01  1    @0 11-0321224
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 Background: Lewy body syndromes (mainly Parkinson's disease and dementia with Lewy bodies) share many clinical features and usually have a slowly progressive course. Some patients may show rapid symptoms progression. Objective: To evaluate clinical and neuropathological features of patients with a rapidly progressive diffuse Lewy Body disease. Methods: Review clinical records and pathological findings of 6 cases with diffuse Lewy Body disease and rapid disease progression (less than 18 months before death). Results: Mean age at disease onset was 72.5 years, and mean disease duration was 9 months. Onset consisted of delirium in 3 patients and rapidly progressive dementia in the other three. All cases presented visual hallucinations and delusions; cognitive symptoms were fluctuating in two, parkinsonism occurred in four, and myoclonus in three. Brain MRI did not show cortical or basal ganglia hyperintensities. Periodic sharp waves were absent on EEG. 14.3.3 protein in CSF was negative. Myocardial 123I-metaiodo-benzyl-guanidine SPECT showed marked reduction in tracer uptake in the 2 patients tested. Neuropathological studies did not identify any particular feature that could differentiate rapidly progressive diffuse Lewy body disease from classical diffuse Lewy body disease. Conclusions: Diffuse Lewy body disease is a possible cause of rapidly progressive dementia and should be included in the differential diagnosis of confusional states of undetermined cause. In patients with rapidly progressive dementia, the presence of fluctuating cognition, parkinsonism, hallucinations, delusions, or severe dysautonomia, should raise the suspicion of diffuse Lewy body disease. Neuroimaging studies such as 123I-metaiodo-benzyl-guanidine myocardial scintigraphy may support the clinical diagnosis of diffuse Lewy body disease.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C03 01  X  FRE  @0 Démence à corps de Lewy @2 NM @5 01
C03 01  X  ENG  @0 Lewy body dementia @2 NM @5 01
C03 01  X  SPA  @0 Demencia cuerpos Lewy @2 NM @5 01
C03 02  X  FRE  @0 Pathologie du système nerveux @5 02
C03 02  X  ENG  @0 Nervous system diseases @5 02
C03 02  X  SPA  @0 Sistema nervioso patología @5 02
C03 03  X  FRE  @0 Corps Lewy @5 09
C03 03  X  ENG  @0 Lewy body @5 09
C03 03  X  SPA  @0 Cuerpo Lewy @5 09
C03 04  X  FRE  @0 Encéphalopathie spongiforme de Creutzfeldt-Jakob @5 10
C03 04  X  ENG  @0 Creutzfeldt-Jakob disease @5 10
C03 04  X  SPA  @0 Encefalopatía espongiforme Creutzfeldt-Jakob @5 10
C03 05  X  FRE  @0 Prion @5 78
C03 05  X  ENG  @0 Prion @5 78
C03 05  X  SPA  @0 Prion @5 78
C03 06  X  FRE  @0 Corps Lewy maladie @4 CD @5 96
C03 06  X  ENG  @0 Lewy body disease @4 CD @5 96
C03 06  X  SPA  @0 Cuerpo Lewy enfermedad @4 CD @5 96
C07 01  X  FRE  @0 Maladie à prions @2 NM
C07 01  X  ENG  @0 Prion disease @2 NM
C07 01  X  SPA  @0 Prion enfermedad @2 NM
C07 02  X  FRE  @0 Infection
C07 02  X  ENG  @0 Infection
C07 02  X  SPA  @0 Infección
C07 03  X  FRE  @0 Pathologie de l'encéphale @5 37
C07 03  X  ENG  @0 Cerebral disorder @5 37
C07 03  X  SPA  @0 Encéfalo patología @5 37
C07 04  X  FRE  @0 Maladie dégénérative @5 38
C07 04  X  ENG  @0 Degenerative disease @5 38
C07 04  X  SPA  @0 Enfermedad degenerativa @5 38
C07 05  X  FRE  @0 Pathologie du système nerveux central @5 39
C07 05  X  ENG  @0 Central nervous system disease @5 39
C07 05  X  SPA  @0 Sistema nervosio central patología @5 39
N21       @1 220
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 11-0321224 INIST
ET : Rapidly Progressive Diffuse Lewy Body Disease
AU : GAIG (Carles); VALLDEORIOLA (Francesc); GELPI (Ellen); EZQUERRA (Mario); LLUFRIU (Sara); BUONGIORNO (Mariateresa); JESUS REY (Maria); JOSE MARTI (Maria); GRAUS (Francesc); TOLOSA (Eduardo)
AF : Neurology Service, Hospital Clinic of Barcelona/Barcelona/Espagne (1 aut., 2 aut., 4 aut., 5 aut., 6 aut., 8 aut., 9 aut., 10 aut.); Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic/Barcelona/Espagne (1 aut., 3 aut., 7 aut., 9 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 7; Pp. 1316-1323; Bibl. 36 ref.
LA : Anglais
EA : Background: Lewy body syndromes (mainly Parkinson's disease and dementia with Lewy bodies) share many clinical features and usually have a slowly progressive course. Some patients may show rapid symptoms progression. Objective: To evaluate clinical and neuropathological features of patients with a rapidly progressive diffuse Lewy Body disease. Methods: Review clinical records and pathological findings of 6 cases with diffuse Lewy Body disease and rapid disease progression (less than 18 months before death). Results: Mean age at disease onset was 72.5 years, and mean disease duration was 9 months. Onset consisted of delirium in 3 patients and rapidly progressive dementia in the other three. All cases presented visual hallucinations and delusions; cognitive symptoms were fluctuating in two, parkinsonism occurred in four, and myoclonus in three. Brain MRI did not show cortical or basal ganglia hyperintensities. Periodic sharp waves were absent on EEG. 14.3.3 protein in CSF was negative. Myocardial 123I-metaiodo-benzyl-guanidine SPECT showed marked reduction in tracer uptake in the 2 patients tested. Neuropathological studies did not identify any particular feature that could differentiate rapidly progressive diffuse Lewy body disease from classical diffuse Lewy body disease. Conclusions: Diffuse Lewy body disease is a possible cause of rapidly progressive dementia and should be included in the differential diagnosis of confusional states of undetermined cause. In patients with rapidly progressive dementia, the presence of fluctuating cognition, parkinsonism, hallucinations, delusions, or severe dysautonomia, should raise the suspicion of diffuse Lewy body disease. Neuroimaging studies such as 123I-metaiodo-benzyl-guanidine myocardial scintigraphy may support the clinical diagnosis of diffuse Lewy body disease.
CC : 002B17; 002B17G
FD : Démence à corps de Lewy; Pathologie du système nerveux; Corps Lewy; Encéphalopathie spongiforme de Creutzfeldt-Jakob; Prion; Corps Lewy maladie
FG : Maladie à prions; Infection; Pathologie de l'encéphale; Maladie dégénérative; Pathologie du système nerveux central
ED : Lewy body dementia; Nervous system diseases; Lewy body; Creutzfeldt-Jakob disease; Prion; Lewy body disease
EG : Prion disease; Infection; Cerebral disorder; Degenerative disease; Central nervous system disease
SD : Demencia cuerpos Lewy; Sistema nervioso patología; Cuerpo Lewy; Encefalopatía espongiforme Creutzfeldt-Jakob; Prion; Cuerpo Lewy enfermedad
LO : INIST-20953.354000190480410180
ID : 11-0321224

Links to Exploration step

Pascal:11-0321224

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Rapidly Progressive Diffuse Lewy Body Disease</title>
<author>
<name sortKey="Gaig, Carles" sort="Gaig, Carles" uniqKey="Gaig C" first="Carles" last="Gaig">Carles Gaig</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Valldeoriola, Francesc" sort="Valldeoriola, Francesc" uniqKey="Valldeoriola F" first="Francesc" last="Valldeoriola">Francesc Valldeoriola</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Gelpi, Ellen" sort="Gelpi, Ellen" uniqKey="Gelpi E" first="Ellen" last="Gelpi">Ellen Gelpi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ezquerra, Mario" sort="Ezquerra, Mario" uniqKey="Ezquerra M" first="Mario" last="Ezquerra">Mario Ezquerra</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Llufriu, Sara" sort="Llufriu, Sara" uniqKey="Llufriu S" first="Sara" last="Llufriu">Sara Llufriu</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Buongiorno, Mariateresa" sort="Buongiorno, Mariateresa" uniqKey="Buongiorno M" first="Mariateresa" last="Buongiorno">Mariateresa Buongiorno</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jesus Rey, Maria" sort="Jesus Rey, Maria" uniqKey="Jesus Rey M" first="Maria" last="Jesus Rey">Maria Jesus Rey</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jose Marti, Maria" sort="Jose Marti, Maria" uniqKey="Jose Marti M" first="Maria" last="Jose Marti">Maria Jose Marti</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Graus, Francesc" sort="Graus, Francesc" uniqKey="Graus F" first="Francesc" last="Graus">Francesc Graus</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0321224</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0321224 INIST</idno>
<idno type="RBID">Pascal:11-0321224</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000542</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Rapidly Progressive Diffuse Lewy Body Disease</title>
<author>
<name sortKey="Gaig, Carles" sort="Gaig, Carles" uniqKey="Gaig C" first="Carles" last="Gaig">Carles Gaig</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Valldeoriola, Francesc" sort="Valldeoriola, Francesc" uniqKey="Valldeoriola F" first="Francesc" last="Valldeoriola">Francesc Valldeoriola</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Gelpi, Ellen" sort="Gelpi, Ellen" uniqKey="Gelpi E" first="Ellen" last="Gelpi">Ellen Gelpi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ezquerra, Mario" sort="Ezquerra, Mario" uniqKey="Ezquerra M" first="Mario" last="Ezquerra">Mario Ezquerra</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Llufriu, Sara" sort="Llufriu, Sara" uniqKey="Llufriu S" first="Sara" last="Llufriu">Sara Llufriu</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Buongiorno, Mariateresa" sort="Buongiorno, Mariateresa" uniqKey="Buongiorno M" first="Mariateresa" last="Buongiorno">Mariateresa Buongiorno</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jesus Rey, Maria" sort="Jesus Rey, Maria" uniqKey="Jesus Rey M" first="Maria" last="Jesus Rey">Maria Jesus Rey</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jose Marti, Maria" sort="Jose Marti, Maria" uniqKey="Jose Marti M" first="Maria" last="Jose Marti">Maria Jose Marti</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Graus, Francesc" sort="Graus, Francesc" uniqKey="Graus F" first="Francesc" last="Graus">Francesc Graus</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Creutzfeldt-Jakob disease</term>
<term>Lewy body</term>
<term>Lewy body dementia</term>
<term>Lewy body disease</term>
<term>Nervous system diseases</term>
<term>Prion</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Démence à corps de Lewy</term>
<term>Pathologie du système nerveux</term>
<term>Corps Lewy</term>
<term>Encéphalopathie spongiforme de Creutzfeldt-Jakob</term>
<term>Prion</term>
<term>Corps Lewy maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Lewy body syndromes (mainly Parkinson's disease and dementia with Lewy bodies) share many clinical features and usually have a slowly progressive course. Some patients may show rapid symptoms progression. Objective: To evaluate clinical and neuropathological features of patients with a rapidly progressive diffuse Lewy Body disease. Methods: Review clinical records and pathological findings of 6 cases with diffuse Lewy Body disease and rapid disease progression (less than 18 months before death). Results: Mean age at disease onset was 72.5 years, and mean disease duration was 9 months. Onset consisted of delirium in 3 patients and rapidly progressive dementia in the other three. All cases presented visual hallucinations and delusions; cognitive symptoms were fluctuating in two, parkinsonism occurred in four, and myoclonus in three. Brain MRI did not show cortical or basal ganglia hyperintensities. Periodic sharp waves were absent on EEG. 14.3.3 protein in CSF was negative. Myocardial
<sup>123</sup>
I-metaiodo-benzyl-guanidine SPECT showed marked reduction in tracer uptake in the 2 patients tested. Neuropathological studies did not identify any particular feature that could differentiate rapidly progressive diffuse Lewy body disease from classical diffuse Lewy body disease. Conclusions: Diffuse Lewy body disease is a possible cause of rapidly progressive dementia and should be included in the differential diagnosis of confusional states of undetermined cause. In patients with rapidly progressive dementia, the presence of fluctuating cognition, parkinsonism, hallucinations, delusions, or severe dysautonomia, should raise the suspicion of diffuse Lewy body disease. Neuroimaging studies such as
<sup>123</sup>
I-metaiodo-benzyl-guanidine myocardial scintigraphy may support the clinical diagnosis of diffuse Lewy body disease.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>26</s2>
</fA05>
<fA06>
<s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Rapidly Progressive Diffuse Lewy Body Disease</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>GAIG (Carles)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>VALLDEORIOLA (Francesc)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>GELPI (Ellen)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>EZQUERRA (Mario)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>LLUFRIU (Sara)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>BUONGIORNO (Mariateresa)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>JESUS REY (Maria)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>JOSE MARTI (Maria)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>GRAUS (Francesc)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>TOLOSA (Eduardo)</s1>
</fA11>
<fA14 i1="01">
<s1>Neurology Service, Hospital Clinic of Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA20>
<s1>1316-1323</s1>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000190480410180</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>36 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0321224</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background: Lewy body syndromes (mainly Parkinson's disease and dementia with Lewy bodies) share many clinical features and usually have a slowly progressive course. Some patients may show rapid symptoms progression. Objective: To evaluate clinical and neuropathological features of patients with a rapidly progressive diffuse Lewy Body disease. Methods: Review clinical records and pathological findings of 6 cases with diffuse Lewy Body disease and rapid disease progression (less than 18 months before death). Results: Mean age at disease onset was 72.5 years, and mean disease duration was 9 months. Onset consisted of delirium in 3 patients and rapidly progressive dementia in the other three. All cases presented visual hallucinations and delusions; cognitive symptoms were fluctuating in two, parkinsonism occurred in four, and myoclonus in three. Brain MRI did not show cortical or basal ganglia hyperintensities. Periodic sharp waves were absent on EEG. 14.3.3 protein in CSF was negative. Myocardial
<sup>123</sup>
I-metaiodo-benzyl-guanidine SPECT showed marked reduction in tracer uptake in the 2 patients tested. Neuropathological studies did not identify any particular feature that could differentiate rapidly progressive diffuse Lewy body disease from classical diffuse Lewy body disease. Conclusions: Diffuse Lewy body disease is a possible cause of rapidly progressive dementia and should be included in the differential diagnosis of confusional states of undetermined cause. In patients with rapidly progressive dementia, the presence of fluctuating cognition, parkinsonism, hallucinations, delusions, or severe dysautonomia, should raise the suspicion of diffuse Lewy body disease. Neuroimaging studies such as
<sup>123</sup>
I-metaiodo-benzyl-guanidine myocardial scintigraphy may support the clinical diagnosis of diffuse Lewy body disease.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Démence à corps de Lewy</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Lewy body dementia</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Demencia cuerpos Lewy</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Pathologie du système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Corps Lewy</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Lewy body</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Cuerpo Lewy</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Encéphalopathie spongiforme de Creutzfeldt-Jakob</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Creutzfeldt-Jakob disease</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Encefalopatía espongiforme Creutzfeldt-Jakob</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Prion</s0>
<s5>78</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Prion</s0>
<s5>78</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Prion</s0>
<s5>78</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Corps Lewy maladie</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Lewy body disease</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Cuerpo Lewy enfermedad</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Maladie à prions</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Prion disease</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Prion enfermedad</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie du système nerveux central</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>39</s5>
</fC07>
<fN21>
<s1>220</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 11-0321224 INIST</NO>
<ET>Rapidly Progressive Diffuse Lewy Body Disease</ET>
<AU>GAIG (Carles); VALLDEORIOLA (Francesc); GELPI (Ellen); EZQUERRA (Mario); LLUFRIU (Sara); BUONGIORNO (Mariateresa); JESUS REY (Maria); JOSE MARTI (Maria); GRAUS (Francesc); TOLOSA (Eduardo)</AU>
<AF>Neurology Service, Hospital Clinic of Barcelona/Barcelona/Espagne (1 aut., 2 aut., 4 aut., 5 aut., 6 aut., 8 aut., 9 aut., 10 aut.); Neurological Tissue Bank, Universitat of Barcelona-Hospital Clinic/Barcelona/Espagne (1 aut., 3 aut., 7 aut., 9 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 7; Pp. 1316-1323; Bibl. 36 ref.</SO>
<LA>Anglais</LA>
<EA>Background: Lewy body syndromes (mainly Parkinson's disease and dementia with Lewy bodies) share many clinical features and usually have a slowly progressive course. Some patients may show rapid symptoms progression. Objective: To evaluate clinical and neuropathological features of patients with a rapidly progressive diffuse Lewy Body disease. Methods: Review clinical records and pathological findings of 6 cases with diffuse Lewy Body disease and rapid disease progression (less than 18 months before death). Results: Mean age at disease onset was 72.5 years, and mean disease duration was 9 months. Onset consisted of delirium in 3 patients and rapidly progressive dementia in the other three. All cases presented visual hallucinations and delusions; cognitive symptoms were fluctuating in two, parkinsonism occurred in four, and myoclonus in three. Brain MRI did not show cortical or basal ganglia hyperintensities. Periodic sharp waves were absent on EEG. 14.3.3 protein in CSF was negative. Myocardial
<sup>123</sup>
I-metaiodo-benzyl-guanidine SPECT showed marked reduction in tracer uptake in the 2 patients tested. Neuropathological studies did not identify any particular feature that could differentiate rapidly progressive diffuse Lewy body disease from classical diffuse Lewy body disease. Conclusions: Diffuse Lewy body disease is a possible cause of rapidly progressive dementia and should be included in the differential diagnosis of confusional states of undetermined cause. In patients with rapidly progressive dementia, the presence of fluctuating cognition, parkinsonism, hallucinations, delusions, or severe dysautonomia, should raise the suspicion of diffuse Lewy body disease. Neuroimaging studies such as
<sup>123</sup>
I-metaiodo-benzyl-guanidine myocardial scintigraphy may support the clinical diagnosis of diffuse Lewy body disease.</EA>
<CC>002B17; 002B17G</CC>
<FD>Démence à corps de Lewy; Pathologie du système nerveux; Corps Lewy; Encéphalopathie spongiforme de Creutzfeldt-Jakob; Prion; Corps Lewy maladie</FD>
<FG>Maladie à prions; Infection; Pathologie de l'encéphale; Maladie dégénérative; Pathologie du système nerveux central</FG>
<ED>Lewy body dementia; Nervous system diseases; Lewy body; Creutzfeldt-Jakob disease; Prion; Lewy body disease</ED>
<EG>Prion disease; Infection; Cerebral disorder; Degenerative disease; Central nervous system disease</EG>
<SD>Demencia cuerpos Lewy; Sistema nervioso patología; Cuerpo Lewy; Encefalopatía espongiforme Creutzfeldt-Jakob; Prion; Cuerpo Lewy enfermedad</SD>
<LO>INIST-20953.354000190480410180</LO>
<ID>11-0321224</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000542 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000542 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0321224
   |texte=   Rapidly Progressive Diffuse Lewy Body Disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024